General Information
Drug ID
DR01392
Drug Name
Betamethasone
Synonyms
betamethasone; 378-44-9; Betadexamethasone; Flubenisolone; Betamethazone; Rinderon; Visubeta; Celestene; Betnelan; Betapredol; Betacortril; Betacorlan; Methazon; Betsolan; Betamamallet; Hormezon; Betasolon; Betametasone; Cidoten; Bebate; Bedifos; Becort; beta-Methasone; Desacort-Beta; Rinderon A; beta-Methasone alcohol; Betametasona; Betafluorene; Betamethasonum; Celestone; Betamethasone cream; Betamethasone alcohol; Betametasone [DCIT]; 9alpha-Fluoro-16beta-methylprednisolone; Celestone Syrup and Tablets; Celeston; Celestona; Cellestoderm; Luxiqo; Betamethasone Base; Betamethasone Valearate; Betamethasonvalerat Mikron; LT00441022; SCH 4831; Beta-Methasone; Beta-Methasone alcohol; Betametasona [INN-Spanish]; Betamethasonum [INN-Latin]; Betnovate (TN); Celestone (TN); Diprolene (TN); Diprosone (TN); Lotrisone (TN); Rinderon (TN); SCH-4831; Betamethasone (JP15/USP/INN); Betamethasone [USAN:BAN:INN:JAN]; Betamethasone [USAN:INN:BAN:JAN]; Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone; 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol; 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione; 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-16beta-methylprednisolone; 9-alpha-Fluoro-16-beta-methylprednisolone; 9alpha-Fluoro-16 beta-methyl-prednisolone; Betamethasone sodium phosphate
Drug Type
Small molecular drug
Indication Asthma [ICD11: CA23] Approved [1]
Therapeutic Class
Antiinflammatory Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9782"></iframe>
3D MOL 2D MOL
Formula
C22H29FO5
Canonical SMILES
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
InChI
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
InChIKey
UREBDLICKHMUKA-DVTGEIKXSA-N
CAS Number
CAS 378-44-9
Pharmaceutical Properties Molecular Weight 392.5 Topological Polar Surface Area 94.8
Heavy Atom Count 28 Rotatable Bond Count 2
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
1.9
PubChem CID
9782
PubChem SID
9066 , 625879 , 3161499 , 7847310 , 7978781 , 8157046 , 10321659 , 11466390 , 11467510 , 11486140 , 12159278 , 14756597 , 15004923 , 24278276 , 24860978 , 24892150 , 26757820 , 29228348 , 46500420 , 46505155 , 46530919 , 47193705 , 47499670 , 47720710 , 47720711 , 47943900 , 48019043 , 48415627 , 49698457 , 50019449 , 50111677 , 53789445 , 56320847 , 56462985 , 57288752 , 57649117 , 57653954 , 75637045 , 85788058 , 87564725 , 87568418 , 92125449 , 93167065 , 103188847 , 103914147 , 104253177 , 104321493 , 121363120 , 124757297 , 124800522
ChEBI ID
ChEBI:3077
TTD Drug ID
D0CW1P
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Betamethasone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm Res. 2003 Nov;20(11):1794-803.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.